Gene · 403
ARL3: ARF like GTPase 3
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ARL3: ARF like GTPase 3. Genes, record 403. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/403
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P36405 | ADP-ribosylation factor-like protein 3 | 182 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents32
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026515744 A | 2026-05-19 | 185 | P36405 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36801 | P36405 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 1822 | P36405 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 1822 | P36405 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 3371 | P36405 | Espacenet |
| WO 2024214081 A1 | 2024-10-17 | 185 | P36405 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 3371 | P36405 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 106342 | P36405 | Espacenet |
| US 11078247 B2 | 2021-08-03 | 768 | P36405 | Espacenet |
| JP 2019054813 A | 2019-04-11 | 217236 | P36405 | Espacenet |
1 to 10 of 32
See all 32 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants486
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ARL3 papers | Newest fiscal year |
|---|---|---|---|
| P30EY014800 | University of Utah Core Vision Research Grant | 8 | 2025 |
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 5 | 2025 |
| T32NS096050 | Training In Systems And Integrative Biology Neuroscience | 4 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30EY005722 | Center Core Grant for Vision Research | 2 | 2025 |
| P30EY007003 | University of Michigan Vision Research Center | 2 | 2025 |
| P30EY025585 | NEI Center Core Grant for Vision Research | 2 | 2025 |
| R01CA268179 | Functional interplay between Hippo and estrogen receptor ESR1 | 2 | 2025 |
| R01DK099160 | Molecular dissection of the ciliary gate | 2 | 2025 |
| R01DK106404 | Obesity in ciliopathies: How neuronal primary cilia control appetite | 2 | 2025 |
1 to 10 of 486Source NIH's project files
See all 486 nih grantsPapers502
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing the impact of plasma protein levels on human brain structure and disorders leveraging integrative multi-omics analysis. | medRxiv | 2026 | 42528609 | PubTator, text mining | PubMed |
| Dual Roles of Ubiquitin-Specific Peptidase 10 (USP10) in Cancer. | Cells | 2026 | 41892309 | PubTator, text mining | PubMed |
| A Novel Heterozygous ARL3 Variant in Non-Syndromic Retinitis Pigmentosa: Clinical and Functional Characterization. | Int J Mol Sci | 2026 | 41828587 | PubTator, text mining | PubMed |
| Organoids for disease modeling and treatment: state-of-the-art. | Exp Hematol Oncol | 2026 | 41545895 | PubTator, text mining | PubMed |
| Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection. | Mol Neurodegener Adv | 2025 | 42751568 | PubTator, text mining | PubMed |
| ARL3 Enhances ERα Stability via USP10 Deubiquitination to Promote Endocrine Resistance and Drive Mitochondrial Metabolic Reprogramming in HR+ Breast Cancer. | Adv Sci (Weinh) | 2025 | 41047477 | PubTator, text mining | PubMed |
| Molecular basis for the activation of outer dynein arms in cilia. | Nat Struct Mol Biol | 2025 | 41023246 | PubTator, text mining | PubMed |
| A conserved mechanism for the retrieval of polyubiquitinated proteins from cilia. | Cell | 2025 | 40840444 | PubTator, text mining | PubMed |
| Spatial regulation of ARL3 and GSF-mediated lipidated cargo trafficking in the primary cilium. | FEBS Lett | 2025 | 40836900 | PubTator, text mining | PubMed |
| Photoaffinity enabled transcriptome-wide identification of splice modulating small molecule-RNA binding events in native cells. | RSC Chem Biol | 2025 | 40226337 | PubTator, text mining | PubMed |
1 to 10 of 502
See all 502 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/403
GET https://conductscience.org/api/genes/v1/403/patents?page=2